Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
Open Access
- 17 February 2011
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 34 (3), 691-696
- https://doi.org/10.2337/dc10-1392
Abstract
OBJECTIVE Urinary liver-type fatty acid–binding protein (L-FABP) is a promising indicator of tubular but not glomerular damage. The aim of this study was to evaluate the clinical usefulness of urinary L-FABP as a prognostic biomarker in impaired diabetic nephropathy in type 2 diabetes. RESEARCH DESIGN AND METHODS This investigation involved a cross-sectional and longitudinal analysis of the relationship between urinary L-FABP levels and progressive nephropathy. Urinary L-FABP was measured with enzyme-linked immunosorbent assay. In the cross-sectional analysis, the association of urinary L-FABP, with the severity of diabetic nephropathy, was investigated in 140 patients with type 2 diabetes and in 412 healthy control subjects. Of the patients in the former study, 104 have been followed for 4 years. The progression of diabetic nephropathy was defined as progressive albuminuria, end-stage renal disease, or induction of hemodialysis. RESULTS Urinary L-FABP levels were progressively increased in subjects with normo-, micro-, or macroalbuminuria and further increased in patients with end-stage renal disease. In the longitudinal analysis, high urinary L-FABP levels were associated with the increase in albuminuria, progression to end-stage renal disease, or induction of hemodialysis. This was particularly demonstrated in the subgroup of patients without renal dysfunction (n = 59), where high urinary L-FABP levels were associated with the progression of diabetic nephropathy. CONCLUSIONS Urinary L-FABP accurately reflected the severity of diabetic nephropathy in type 2 diabetes, and its level was high in the patients with normoalbuminuria. Moreover, higher urinary L-FABP was a risk factor for progression of diabetic nephropathy.Keywords
This publication has 9 references indexed in Scilit:
- Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic PatientsDiabetes Care, 2010
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathyNature Clinical Practice Nephrology, 2008
- Renal L-Type Fatty Acid–Binding Protein in Acute Ischemic InjuryJournal of the American Society of Nephrology, 2007
- Chronic Hypoxia and Tubulointerstitial InjuryJournal of the American Society of Nephrology, 2006
- Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal diseaseJournal of Laboratory and Clinical Medicine, 2004
- Structural and functional aspects of cytosolic fatty acid-binding proteinsProstaglandins, Leukotrienes & Essential Fatty Acids, 1993
- Structural and functional features of different types of cytoplasmic fatty acid-binding proteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- The Metabolic Significance of Mammalian Fatty-Acid-Binding Proteins: Abundant Proteins in Search of a FunctionAnnual Review of Nutrition, 1987